Activity Description:

This activity fosters a multidisciplinary team approach to care through peer-to-peer discussion and collaboration. By reviewing radiological and pathological findings, immunohistochemical testing, and other diagnostic information, the team works together to enhance diagnosis and treatment across the continuum of GI cancer care. These discussions support the use of best practices, advanced treatment methodologies, and coordinated care strategies to improve patient-centered outcomes.

Target Audience:

The intended audience are Medical Oncologists, Radiation Oncologists, GI Cancer Surgeons, General Surgeons, Pathologists, Radiologists, Nurses, Patient Care Facilitators and all personnel involved in the care of the breast cancer patient.

Learning Objective:

• Identify best practices across relevant disciplines to support evidence-based management of GI conditions.
• Apply advanced treatment methodologies to improve decision making in complex gastrointestinal oncology cases.
• Integrate multidisciplinary collaboration strategies into patient care to develop effective treatment plans that support improved clinical outcomes. 

Moderator:

Shawn Young, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.​

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence all parties in control of content are required to disclose all conflicts of interest with ACCME defined ineligible companies. None of the planners, faculty, and those in control of this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.​